Editorial: HIV/HBV and/or HCV infections and hepatotoxicity in pregnant and non-pregnant women

George Uchenna Eleje; Chinyere Ukamaka Onubogu; Emeka Philip Igbodike; Sayeed Mohammed Firdous

doi:10.3389/frph.2025.1538380

August 22, 2025Frontiers in Reproductive HealthOpen Access

Editorial: HIV/HBV and/or HCV infections and hepatotoxicity in pregnant and non-pregnant women

View Full Paper

Ask AI

Bookmark

Share

Key Points

HCV infection increases risks of hepatotoxicity in women, particularly impacting pregnant individuals with specific birth outcomes.
Study finds that HBsAg carriers experience complications like intrahepatic cholestasis of pregnancy, requiring tailored prenatal care.
Retrospective cohort analysis shows that effective antiviral treatments and regular screenings can improve maternal health during pregnancy.
Integrated testing panels may improve healthcare delivery, enhancing the detection of viral infections in low-resource settings.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Editorial reveals challenges of managing HIV, HBV, and HCV infections in pregnant and non-pregnant women, indicating a need for enhanced healthcare strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Eleje et al. (2025) studied this question.

synapsesocial.com/papers/68af55ccad7bf08b1eadbef7 https://doi.org/10.3389/frph.2025.1538380

View Full Paper

Ask AI

Bookmark

Share

Editorial: HIV/HBV and/or HCV infections and hepatotoxicity in pregnant and non-pregnant women

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Editorial: HIV/HBV and/or HCV infections and hepatotoxicity in pregnant and non-pregnant women

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading